Eskayef Pharmaceuticals Ltd. (SK+F) is one of Bangladesh’s leading pharmaceutical companies, committed to improving lives through innovation, quality, and global standards. As a subsidiary of Transcom Group, one of the most respected business conglomerates in Bangladesh, Eskayef has grown into a trusted name both locally and internationally.

Founded with a vision to produce world-class healthcare solutions, Eskayef manufactures a wide range of pharmaceuticals, animal health, and nutritional products, all in compliance with the latest global cGMP, WHO, and FDA standards. Its state-of-the-art manufacturing facilities—including the Sterile Manufacturing Unit, Ophthalmic Unit, and the Dedicated Oncology Plant—reflect the company’s commitment to quality and innovation.

Under the dynamic leadership of Simeen Rahman, Managing Director & Group CEO, Eskayef continues to expand its footprint across more than 50 countries, exporting life-saving medications to Europe, Asia, Africa, and Latin America.

With a robust pipeline, skilled workforce, and deep dedication to ethical practices, Eskayef is not just producing medicine—it’s making a meaningful difference in global healthcare.